Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Clinical, Preclinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Market Size & Trends
The global personalized medicine outsourcing market size was estimated at USD 101.62 billion in 2023 and is projected t%li%grow at a CAGR of 12.21% from 2024 t%li%2030. The increasing awareness about the benefits of personalized medicine, increasing application of personalized medicine in various diseases, such as rare diseases, cancer, infectious diseases, and others, the requirement of specialized expertise, and the benefits of outsourcing the services are some of the major factors driving the market growth.
The increasing prevalence of diseases such as chronic diseases, rare diseases and infectious diseases is further increasing the demand for these medicines as it offers enhanced patient outcomes. According t%li%the data published by American Cancer Society, cancer was expected t%li%cause around 609,820 deaths in the U.S. in 2023 and was expected t%li%diagnose over 1.9 people in the same year.
The applications of personalized medicine have significantly increased in cancer care, which is one of the major factors contributing t%li%the market growth. Personalized medicine or precision medicine is utilized for several purposes in oncology such as early detection of certain cancers, identifying people with higher cancer risk, evaluation of treatment alternatives, and effect of treatment on patient’s health. As the burden of these diseases increase, the demand for personalized medicine is als%li%anticipated t%li%witness growth.
Furthermore, CROs and CDMOs have witnessed significant growth during the past few years as most of the pharmaceutical companies are opting t%li%outsource their drug development and manufacturing activities t%li%these outsourcing companies. Building and maintaining internal capabilities for all aspects of personalized medicine, from development t%li%manufacturing, requires several resources and investments. Therefore, outsourcing these activities can allow companies t%li%access specialized expertise, infrastructure, and resources according t%li%their needs, thereby offering a cost-effective solution. Moreover, the complexity and risk associated with the development of personalized solutions, such as failures in the preclinical and clinical phases, offer a significant risk factor, while CROs can handle the complexities of later-stage development and manufacturing, allowing companies t%li%streamline their operations and enhance their efficiency.
The awareness about personalized medicine has significantly increased in recent years owing t%li%its several benefits, such as reducing trial and error prescribing, helping in avoiding adverse drug reactions, and shifting the medical emphasis from prevention t%li%reaction. Personalized medicine offers the ability t%li%use molecular markers that can indicate the disease risk or presence even before clinical signs and symptoms appear, allowing for early treatments of diseases and thereby improving patient outcomes.
Similarly, the patient’s non-compliance with offered treatment and medication can lead t%li%adverse health effects such as Adverse Drug Reactions (ADR), which have been on a significant rise in past years. Thus, increasing cases of ADRs would boost the demand for better treatment options among people further driving the demand for personalized medicine. For instance, according t%li%an article published by the National Institute of Health (NIH) in January 2024, there were around 1.25 million serious adverse effects and approximately 175,000 deaths were recorded in the U.S. in 2022.
Global Personalized Medicine Outsourcing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global personalized medicine outsourcing market report based on phase, application, service, type, end-use, and region.
Market Size & Trends
The global personalized medicine outsourcing market size was estimated at USD 101.62 billion in 2023 and is projected t%li%grow at a CAGR of 12.21% from 2024 t%li%2030. The increasing awareness about the benefits of personalized medicine, increasing application of personalized medicine in various diseases, such as rare diseases, cancer, infectious diseases, and others, the requirement of specialized expertise, and the benefits of outsourcing the services are some of the major factors driving the market growth.
The increasing prevalence of diseases such as chronic diseases, rare diseases and infectious diseases is further increasing the demand for these medicines as it offers enhanced patient outcomes. According t%li%the data published by American Cancer Society, cancer was expected t%li%cause around 609,820 deaths in the U.S. in 2023 and was expected t%li%diagnose over 1.9 people in the same year.
The applications of personalized medicine have significantly increased in cancer care, which is one of the major factors contributing t%li%the market growth. Personalized medicine or precision medicine is utilized for several purposes in oncology such as early detection of certain cancers, identifying people with higher cancer risk, evaluation of treatment alternatives, and effect of treatment on patient’s health. As the burden of these diseases increase, the demand for personalized medicine is als%li%anticipated t%li%witness growth.
Furthermore, CROs and CDMOs have witnessed significant growth during the past few years as most of the pharmaceutical companies are opting t%li%outsource their drug development and manufacturing activities t%li%these outsourcing companies. Building and maintaining internal capabilities for all aspects of personalized medicine, from development t%li%manufacturing, requires several resources and investments. Therefore, outsourcing these activities can allow companies t%li%access specialized expertise, infrastructure, and resources according t%li%their needs, thereby offering a cost-effective solution. Moreover, the complexity and risk associated with the development of personalized solutions, such as failures in the preclinical and clinical phases, offer a significant risk factor, while CROs can handle the complexities of later-stage development and manufacturing, allowing companies t%li%streamline their operations and enhance their efficiency.
The awareness about personalized medicine has significantly increased in recent years owing t%li%its several benefits, such as reducing trial and error prescribing, helping in avoiding adverse drug reactions, and shifting the medical emphasis from prevention t%li%reaction. Personalized medicine offers the ability t%li%use molecular markers that can indicate the disease risk or presence even before clinical signs and symptoms appear, allowing for early treatments of diseases and thereby improving patient outcomes.
Similarly, the patient’s non-compliance with offered treatment and medication can lead t%li%adverse health effects such as Adverse Drug Reactions (ADR), which have been on a significant rise in past years. Thus, increasing cases of ADRs would boost the demand for better treatment options among people further driving the demand for personalized medicine. For instance, according t%li%an article published by the National Institute of Health (NIH) in January 2024, there were around 1.25 million serious adverse effects and approximately 175,000 deaths were recorded in the U.S. in 2022.
Global Personalized Medicine Outsourcing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global personalized medicine outsourcing market report based on phase, application, service, type, end-use, and region.
- Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Preclinical
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Rare Diseases
- Infectious Diseases
- Others
- Service Outlook (Revenue, USD Million, 2018 - 2030)
- Contract Manufacturing
- Contact Development
- Type Outlook (Revenue, USD Million, 2018 - 2030)
- Inhibitor Drugs
- Monoclonal Antibodies
- Cell & Gene Therapy
- Other Therapeutic Products
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical Companies
- Biotechnology Companies
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Phase Segment
1.2.2. Application Segment
1.2.3. Service Segment
1.2.4. Type Segment
1.2.5. End use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. PERSONALIZED MEDICINE OUTSOURCING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic and rare diseases
3.2.1.2. Increasing awareness about the benefits of personalized medicine
3.2.1.3. Increasing application of personalized medicine in various diseases
3.2.1.4. Requirement of specialized expertise for personalized medicine development and manufacturing
3.2.2. Market restraints analysis
3.2.2.1. Data Privacy Concerns
3.3. Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. PERSONALIZED MEDICINE OUTSOURCING MARKET: PHASE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Personalized Medicine Outsourcing Market Phase Movement Analysis
4.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
4.4. Clinical
4.4.1. Clinical market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Phase I
4.4.2.1. Phase I market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Phase II
4.4.3.1. Phase II market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Phase III
4.4.4.1. Phase III market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Phase IV
4.4.5.1. Phase IV market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Preclinical
4.5.1. Preclinical market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. PERSONALIZED MEDICINE OUTSOURCING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Personalized Medicine Outsourcing Market Application Movement Analysis
5.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Oncology
5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Rare Diseases
5.5.1. Rare Diseases market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. PERSONALIZED MEDICINE OUTSOURCING MARKET: SERVICE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Personalized Medicine Outsourcing Market Service Movement Analysis
6.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
6.4. Contract Manufacturing
6.4.1. Contract Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Contact Development
6.5.1. Contact Development market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. PERSONALIZED MEDICINE OUTSOURCING MARKET: TYPE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Global Personalized Medicine Outsourcing Market Type Movement Analysis
7.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
7.4. Inhibitor Drugs
7.4.1. Inhibitor Drugs market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Monoclonal Antibodies
7.5.1. Monoclonal Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Cell & Gene Therapy
7.6.1. Cell & Gene Therapy market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. PERSONALIZED MEDICINE OUTSOURCING MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Global Personalized Medicine Outsourcing Market End use Movement Analysis
8.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
8.4. Pharmaceutical Companies
8.4.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Biotechnology Companies
8.5.1. Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Others
8.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. PERSONALIZED MEDICINE OUTSOURCING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Target disease prevalence
9.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Target disease prevalence
9.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Target disease prevalence
9.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Europe
9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Target disease prevalence
9.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Target disease prevalence
9.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. France
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Target disease prevalence
9.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Target disease prevalence
9.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Target disease prevalence
9.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key country dynamics
9.5.7.2. Competitive scenario
9.5.7.3. Regulatory framework
9.5.7.4. Target disease prevalence
9.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.5.8. Sweden
9.5.8.1. Key country dynamics
9.5.8.2. Competitive scenario
9.5.8.3. Regulatory framework
9.5.8.4. Target disease prevalence
9.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.5.9. Denmark
9.5.9.1. Key country dynamics
9.5.9.2. Competitive scenario
9.5.9.3. Regulatory framework
9.5.9.4. Target disease prevalence
9.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Target disease prevalence
9.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. China
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Target disease prevalence
9.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. India
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. Regulatory framework
9.6.4.4. Target disease prevalence
9.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Australia
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Regulatory framework
9.6.5.4. Target disease prevalence
9.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. South Korea
9.6.6.1. Key country dynamics
9.6.6.2. Competitive scenario
9.6.6.3. Regulatory framework
9.6.6.4. Target disease prevalence
9.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key country dynamics
9.6.7.2. Competitive scenario
9.6.7.3. Target disease prevalence
9.6.7.4. Regulatory framework
9.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Target disease prevalence
9.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Target disease prevalence
9.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.8. MEA
9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory framework
9.8.2.4. Target disease prevalence
9.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory framework
9.8.3.4. Target disease prevalence
9.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key country dynamics
9.8.4.2. Competitive scenario
9.8.4.3. Regulatory framework
9.8.4.4. Target disease prevalence
9.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key country dynamics
9.8.5.2. Competitive scenario
9.8.5.3. Regulatory framework
9.8.5.4. Target disease prevalence
9.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Parexel International (MA) Corporation
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Syneos Health
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Catalent, Inc
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. ICON
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Lonza
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Syngene International Limited
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. HCL Technologies Limited
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Infosys Limited
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Fujirebio
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Aurigene Pharmaceutical Services Ltd.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Phase Segment
1.2.2. Application Segment
1.2.3. Service Segment
1.2.4. Type Segment
1.2.5. End use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. PERSONALIZED MEDICINE OUTSOURCING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic and rare diseases
3.2.1.2. Increasing awareness about the benefits of personalized medicine
3.2.1.3. Increasing application of personalized medicine in various diseases
3.2.1.4. Requirement of specialized expertise for personalized medicine development and manufacturing
3.2.2. Market restraints analysis
3.2.2.1. Data Privacy Concerns
3.3. Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. PERSONALIZED MEDICINE OUTSOURCING MARKET: PHASE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Personalized Medicine Outsourcing Market Phase Movement Analysis
4.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
4.4. Clinical
4.4.1. Clinical market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Phase I
4.4.2.1. Phase I market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Phase II
4.4.3.1. Phase II market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Phase III
4.4.4.1. Phase III market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Phase IV
4.4.5.1. Phase IV market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Preclinical
4.5.1. Preclinical market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. PERSONALIZED MEDICINE OUTSOURCING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Personalized Medicine Outsourcing Market Application Movement Analysis
5.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Oncology
5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Rare Diseases
5.5.1. Rare Diseases market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. PERSONALIZED MEDICINE OUTSOURCING MARKET: SERVICE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Personalized Medicine Outsourcing Market Service Movement Analysis
6.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
6.4. Contract Manufacturing
6.4.1. Contract Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Contact Development
6.5.1. Contact Development market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. PERSONALIZED MEDICINE OUTSOURCING MARKET: TYPE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Global Personalized Medicine Outsourcing Market Type Movement Analysis
7.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
7.4. Inhibitor Drugs
7.4.1. Inhibitor Drugs market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Monoclonal Antibodies
7.5.1. Monoclonal Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Cell & Gene Therapy
7.6.1. Cell & Gene Therapy market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. PERSONALIZED MEDICINE OUTSOURCING MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Global Personalized Medicine Outsourcing Market End use Movement Analysis
8.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
8.4. Pharmaceutical Companies
8.4.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Biotechnology Companies
8.5.1. Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Others
8.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. PERSONALIZED MEDICINE OUTSOURCING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Target disease prevalence
9.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Target disease prevalence
9.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Target disease prevalence
9.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Europe
9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Target disease prevalence
9.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Target disease prevalence
9.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. France
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Target disease prevalence
9.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Target disease prevalence
9.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Target disease prevalence
9.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key country dynamics
9.5.7.2. Competitive scenario
9.5.7.3. Regulatory framework
9.5.7.4. Target disease prevalence
9.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.5.8. Sweden
9.5.8.1. Key country dynamics
9.5.8.2. Competitive scenario
9.5.8.3. Regulatory framework
9.5.8.4. Target disease prevalence
9.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.5.9. Denmark
9.5.9.1. Key country dynamics
9.5.9.2. Competitive scenario
9.5.9.3. Regulatory framework
9.5.9.4. Target disease prevalence
9.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Target disease prevalence
9.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. China
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Target disease prevalence
9.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. India
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. Regulatory framework
9.6.4.4. Target disease prevalence
9.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Australia
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Regulatory framework
9.6.5.4. Target disease prevalence
9.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. South Korea
9.6.6.1. Key country dynamics
9.6.6.2. Competitive scenario
9.6.6.3. Regulatory framework
9.6.6.4. Target disease prevalence
9.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key country dynamics
9.6.7.2. Competitive scenario
9.6.7.3. Target disease prevalence
9.6.7.4. Regulatory framework
9.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Target disease prevalence
9.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Target disease prevalence
9.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.8. MEA
9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory framework
9.8.2.4. Target disease prevalence
9.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory framework
9.8.3.4. Target disease prevalence
9.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key country dynamics
9.8.4.2. Competitive scenario
9.8.4.3. Regulatory framework
9.8.4.4. Target disease prevalence
9.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key country dynamics
9.8.5.2. Competitive scenario
9.8.5.3. Regulatory framework
9.8.5.4. Target disease prevalence
9.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Parexel International (MA) Corporation
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Syneos Health
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Catalent, Inc
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. ICON
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Lonza
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Syngene International Limited
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. HCL Technologies Limited
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Infosys Limited
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Fujirebio
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Aurigene Pharmaceutical Services Ltd.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Global personalized medicine outsourcing market, by region, 2018 - 2030 (USD Million)
Table 3 Global personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 4 Global personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 5 Global personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 6 Global personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 7 Global personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 8 North America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 9 North America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 10 North America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 11 North America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 12 North America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 13 North America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 14 U.S. personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 15 U.S. personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 17 U.S. personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 18 U.S. personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 19 Canada personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 20 Canada personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 21 Canada personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 22 Canada personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 23 Canada personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 24 Mexico personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 25 Mexico personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 26 Mexico personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 27 Mexico personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 28 Mexico personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 29 Europe personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 30 Europe personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 31 Europe personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 32 Europe personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 33 Europe personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 34 Europe personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 35 Germany personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 36 Germany personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 37 Germany personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 38 Germany personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 39 Germany personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 40 UK personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 41 UK personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 42 UK personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 43 UK personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 44 UK personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 45 France personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 46 France personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 47 France personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 48 France personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 49 France personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 50 Italy personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 51 Italy personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 52 Italy personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 53 Italy personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 54 Italy personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 55 Spain personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 56 Spain personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 57 Spain personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 58 Spain personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 59 Spain personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 60 Denmark personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 61 Denmark personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 62 Denmark personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 63 Denmark personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 64 Denmark personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 65 Sweden personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 66 Sweden personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 67 Sweden personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 68 Sweden personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 69 Sweden personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 70 Norway personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 71 Norway personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 72 Norway personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 73 Norway personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 74 Norway personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 76 Asia Pacific personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 77 Asia Pacific personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 78 Asia Pacific personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 79 Asia Pacific personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 80 Asia Pacific personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 81 China personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 82 China personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 83 China personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 84 China personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 85 China personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 86 Japan personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 87 Japan personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 88 Japan personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 89 Japan personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 90 Japan personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 91 India personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 92 India personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 93 India personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 94 India personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 95 India personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 96 South Korea personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 97 South Korea personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 98 South Korea personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 99 South Korea personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 100 South Korea personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 101 Australia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 102 Australia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 103 Australia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 104 Australia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 105 Australia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 106 Thailand personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 107 Thailand personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 108 Thailand personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 109 Thailand personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 110 Thailand personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 111 Latin America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 112 Latin America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 113 Latin America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 114 Latin America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 115 Latin America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 116 Latin America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 117 Brazil personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 118 Brazil personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 119 Brazil personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 120 Brazil personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 121 Brazil personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 122 Argentina personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 123 Argentina personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 124 Argentina personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 125 Argentina personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 126 Argentina personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 127 MEA personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 128 MEA personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 129 MEA personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 130 MEA personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 131 MEA personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 132 MEA personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 133 South Africa personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 134 South Africa personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 135 South Africa personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 136 South Africa personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 137 South Africa personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 143 UAE personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 144 UAE personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 145 UAE personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 146 UAE personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 147 UAE personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 148 Kuwait personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 149 Kuwait personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 150 Kuwait personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 151 Kuwait personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 152 Kuwait personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Global personalized medicine outsourcing market, by region, 2018 - 2030 (USD Million)
Table 3 Global personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 4 Global personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 5 Global personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 6 Global personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 7 Global personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 8 North America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 9 North America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 10 North America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 11 North America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 12 North America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 13 North America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 14 U.S. personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 15 U.S. personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 17 U.S. personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 18 U.S. personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 19 Canada personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 20 Canada personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 21 Canada personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 22 Canada personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 23 Canada personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 24 Mexico personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 25 Mexico personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 26 Mexico personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 27 Mexico personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 28 Mexico personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 29 Europe personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 30 Europe personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 31 Europe personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 32 Europe personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 33 Europe personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 34 Europe personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 35 Germany personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 36 Germany personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 37 Germany personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 38 Germany personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 39 Germany personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 40 UK personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 41 UK personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 42 UK personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 43 UK personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 44 UK personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 45 France personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 46 France personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 47 France personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 48 France personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 49 France personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 50 Italy personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 51 Italy personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 52 Italy personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 53 Italy personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 54 Italy personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 55 Spain personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 56 Spain personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 57 Spain personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 58 Spain personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 59 Spain personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 60 Denmark personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 61 Denmark personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 62 Denmark personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 63 Denmark personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 64 Denmark personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 65 Sweden personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 66 Sweden personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 67 Sweden personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 68 Sweden personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 69 Sweden personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 70 Norway personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 71 Norway personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 72 Norway personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 73 Norway personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 74 Norway personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 76 Asia Pacific personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 77 Asia Pacific personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 78 Asia Pacific personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 79 Asia Pacific personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 80 Asia Pacific personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 81 China personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 82 China personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 83 China personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 84 China personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 85 China personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 86 Japan personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 87 Japan personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 88 Japan personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 89 Japan personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 90 Japan personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 91 India personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 92 India personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 93 India personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 94 India personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 95 India personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 96 South Korea personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 97 South Korea personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 98 South Korea personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 99 South Korea personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 100 South Korea personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 101 Australia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 102 Australia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 103 Australia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 104 Australia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 105 Australia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 106 Thailand personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 107 Thailand personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 108 Thailand personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 109 Thailand personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 110 Thailand personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 111 Latin America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 112 Latin America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 113 Latin America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 114 Latin America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 115 Latin America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 116 Latin America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 117 Brazil personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 118 Brazil personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 119 Brazil personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 120 Brazil personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 121 Brazil personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 122 Argentina personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 123 Argentina personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 124 Argentina personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 125 Argentina personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 126 Argentina personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 127 MEA personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
Table 128 MEA personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 129 MEA personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 130 MEA personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 131 MEA personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 132 MEA personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 133 South Africa personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 134 South Africa personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 135 South Africa personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 136 South Africa personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 137 South Africa personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 143 UAE personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 144 UAE personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 145 UAE personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 146 UAE personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 147 UAE personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
Table 148 Kuwait personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
Table 149 Kuwait personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
Table 150 Kuwait personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
Table 151 Kuwait personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
Table 152 Kuwait personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Needle Coke Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Data Analysis Models
Fig. 4 Market Production And Validation
Fig. 5 Data Validating & Publishing
Fig. 6 Needle Coke Market Snapshot
Fig. 7 Needle Coke Market Segmental Outlook, 2023 (Kilotons) (USD Million)
Fig. 8 Needle Coke Market: Competitive Insights
Fig. 9 Global Needle Coke Market Value Chain Analysis
Fig. 10 Needle Coke Market Dynamics
Fig. 11 Needle Coke Market: Porter's Analysis
Fig. 12 Needle Coke Market: Pestel Analysis
Fig. 13 Needle Coke Market Analysis & Segment Forecast, By Super-Premium, 2018 - 2030 (Kilotons) (USD Million)
Fig. 14 Needle Coke Market Analysis & Segment Forecast, Premium-Grade, 2018 - 2030 (Kilotons) (USD Million)
Fig. 15 Needle Coke Market Analysis & Segment Forecast, Intermediate Grade, 2018 - 2030 (Kilotons) (USD Million)
Fig. 16 Needle Coke Market Analysis & Segment Forecast, By Application, 2018 - 2030 (Kilotons) (USD Million)
Fig. 17 Needle Coke Market Analysis & Segment Forecast, in Electrode 2018 - 2030 (Kilotons) (USD Million)
Fig. 18 Needle Coke Market Analysis & Segment Forecast, in Silicon Metals & Ferroalloys 2018 - 2030 (Kilotons) (USD Million)
Fig. 19 Needle Coke Market Analysis & Segment Forecast, in Rubber Compounds 2018 - 2030 (Kilotons) (USD Million)
Fig. 20 Needle Coke Market Analysis & Segment Forecast, in Others 2018 - 2030 (Kilotons) (USD Million)
Fig. 21 Needle Coke Market, By Region, 2023 & 2030 (%)
Fig. 22 North America Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 23 U.S. Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 24 Canada Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 25 Europe Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 26 Germany Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 27 UK Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 28 Italy Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 29 Asia Pacific Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 30 China Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 31 India Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 32 Japan Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 33 Latin America Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 34 Brazil Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 35 Mexico Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 36 Middle East & Africa Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 37 Needle Coke Market: Company Categorization
Fig. 38 Needle Coke Market: Company Market Share Analysis
Fig. 39 Needle Coke Market: Company Market Positioning Analysis
Fig. 40 Needle Coke Market: Strategy Mapping
Fig. 1 Needle Coke Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Data Analysis Models
Fig. 4 Market Production And Validation
Fig. 5 Data Validating & Publishing
Fig. 6 Needle Coke Market Snapshot
Fig. 7 Needle Coke Market Segmental Outlook, 2023 (Kilotons) (USD Million)
Fig. 8 Needle Coke Market: Competitive Insights
Fig. 9 Global Needle Coke Market Value Chain Analysis
Fig. 10 Needle Coke Market Dynamics
Fig. 11 Needle Coke Market: Porter's Analysis
Fig. 12 Needle Coke Market: Pestel Analysis
Fig. 13 Needle Coke Market Analysis & Segment Forecast, By Super-Premium, 2018 - 2030 (Kilotons) (USD Million)
Fig. 14 Needle Coke Market Analysis & Segment Forecast, Premium-Grade, 2018 - 2030 (Kilotons) (USD Million)
Fig. 15 Needle Coke Market Analysis & Segment Forecast, Intermediate Grade, 2018 - 2030 (Kilotons) (USD Million)
Fig. 16 Needle Coke Market Analysis & Segment Forecast, By Application, 2018 - 2030 (Kilotons) (USD Million)
Fig. 17 Needle Coke Market Analysis & Segment Forecast, in Electrode 2018 - 2030 (Kilotons) (USD Million)
Fig. 18 Needle Coke Market Analysis & Segment Forecast, in Silicon Metals & Ferroalloys 2018 - 2030 (Kilotons) (USD Million)
Fig. 19 Needle Coke Market Analysis & Segment Forecast, in Rubber Compounds 2018 - 2030 (Kilotons) (USD Million)
Fig. 20 Needle Coke Market Analysis & Segment Forecast, in Others 2018 - 2030 (Kilotons) (USD Million)
Fig. 21 Needle Coke Market, By Region, 2023 & 2030 (%)
Fig. 22 North America Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 23 U.S. Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 24 Canada Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 25 Europe Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 26 Germany Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 27 UK Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 28 Italy Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 29 Asia Pacific Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 30 China Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 31 India Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 32 Japan Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 33 Latin America Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 34 Brazil Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 35 Mexico Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 36 Middle East & Africa Needle Coke Market Analysis & Segment Forecast, 2018 - 2030 (Kilotons) (USD Million)
Fig. 37 Needle Coke Market: Company Categorization
Fig. 38 Needle Coke Market: Company Market Share Analysis
Fig. 39 Needle Coke Market: Company Market Positioning Analysis
Fig. 40 Needle Coke Market: Strategy Mapping
